Lv0
0 积分 2025-12-15 加入
Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer—Long-Term Results of a Randomized Clinical Trial
53分钟前
已完结
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
1小时前
已完结
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
1小时前
已完结
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
1小时前
已完结
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
19小时前
已完结
Glycolysis, a driving force of rheumatoid arthritis
27天前
已完结
MRI histogram and Visually AcceSAble Rembrandt Images features nomogram to predict PD-L1 levels in glioblastoma
1个月前
已完结
皖公网安备34019202002308
